The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population

The uninsured population has much to gain from affordable sources of prescription medications. No prior studies have assessed the prevalence and predictors of low-cost generic drug programs (LCGP) use in the uninsured population in the United States. A cross-sectional study was conducted using data...

Full description

Bibliographic Details
Main Authors: Joshua D. Brown, Nathan J. Pauly, Jeffery C. Talbert
Format: Article
Language:English
Published: MDPI AG 2016-03-01
Series:Pharmacy
Subjects:
Online Access:http://www.mdpi.com/2226-4787/4/1/14
_version_ 1811307389636313088
author Joshua D. Brown
Nathan J. Pauly
Jeffery C. Talbert
author_facet Joshua D. Brown
Nathan J. Pauly
Jeffery C. Talbert
author_sort Joshua D. Brown
collection DOAJ
description The uninsured population has much to gain from affordable sources of prescription medications. No prior studies have assessed the prevalence and predictors of low-cost generic drug programs (LCGP) use in the uninsured population in the United States. A cross-sectional study was conducted using data from the Medical Expenditure Panel Survey (MEPS) during 2007–2012 including individuals aged 18 and older who were uninsured for the entire 2-year period they were in MEPS. The proportions of LCGP fills and users was tracked each year and logistic regression was used to assess significant factors associated with LCGP use. A total of 8.3 million uninsured individuals were represented by the sample and 39.9% of these used an LCGP. Differences between users and non-users included higher age, gender, year of participation, and number of medications filled. The proportion of fills and users via LCGPs increased over the 2007–2012 study period. Healthcare providers, especially pharmacists, should make uninsured patients aware of this source of affordable medications.
first_indexed 2024-04-13T09:03:30Z
format Article
id doaj.art-acb23ba6a8bc4fb184daf5b029fd7f0f
institution Directory Open Access Journal
issn 2226-4787
language English
last_indexed 2024-04-13T09:03:30Z
publishDate 2016-03-01
publisher MDPI AG
record_format Article
series Pharmacy
spelling doaj.art-acb23ba6a8bc4fb184daf5b029fd7f0f2022-12-22T02:53:03ZengMDPI AGPharmacy2226-47872016-03-01411410.3390/pharmacy4010014pharmacy4010014The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured PopulationJoshua D. Brown0Nathan J. Pauly1Jeffery C. Talbert2Institute for Pharmaceutical Outcomes & Policy, Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, 789 S. Limestone St., Lexington, KY 40506, USAInstitute for Pharmaceutical Outcomes & Policy, Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, 789 S. Limestone St., Lexington, KY 40506, USAInstitute for Pharmaceutical Outcomes & Policy, Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, 789 S. Limestone St., Lexington, KY 40506, USAThe uninsured population has much to gain from affordable sources of prescription medications. No prior studies have assessed the prevalence and predictors of low-cost generic drug programs (LCGP) use in the uninsured population in the United States. A cross-sectional study was conducted using data from the Medical Expenditure Panel Survey (MEPS) during 2007–2012 including individuals aged 18 and older who were uninsured for the entire 2-year period they were in MEPS. The proportions of LCGP fills and users was tracked each year and logistic regression was used to assess significant factors associated with LCGP use. A total of 8.3 million uninsured individuals were represented by the sample and 39.9% of these used an LCGP. Differences between users and non-users included higher age, gender, year of participation, and number of medications filled. The proportion of fills and users via LCGPs increased over the 2007–2012 study period. Healthcare providers, especially pharmacists, should make uninsured patients aware of this source of affordable medications.http://www.mdpi.com/2226-4787/4/1/14uninsuredgeneric drugslow-cost genericgeneric drug discount programsMEPSaccess
spellingShingle Joshua D. Brown
Nathan J. Pauly
Jeffery C. Talbert
The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population
Pharmacy
uninsured
generic drugs
low-cost generic
generic drug discount programs
MEPS
access
title The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population
title_full The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population
title_fullStr The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population
title_full_unstemmed The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population
title_short The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population
title_sort prevalence and predictors of low cost generic program use in a nationally representative uninsured population
topic uninsured
generic drugs
low-cost generic
generic drug discount programs
MEPS
access
url http://www.mdpi.com/2226-4787/4/1/14
work_keys_str_mv AT joshuadbrown theprevalenceandpredictorsoflowcostgenericprogramuseinanationallyrepresentativeuninsuredpopulation
AT nathanjpauly theprevalenceandpredictorsoflowcostgenericprogramuseinanationallyrepresentativeuninsuredpopulation
AT jefferyctalbert theprevalenceandpredictorsoflowcostgenericprogramuseinanationallyrepresentativeuninsuredpopulation
AT joshuadbrown prevalenceandpredictorsoflowcostgenericprogramuseinanationallyrepresentativeuninsuredpopulation
AT nathanjpauly prevalenceandpredictorsoflowcostgenericprogramuseinanationallyrepresentativeuninsuredpopulation
AT jefferyctalbert prevalenceandpredictorsoflowcostgenericprogramuseinanationallyrepresentativeuninsuredpopulation